title: Blood donor screening or 'over-screening': how far to go in avoiding transmission of infectious agents?
authors.forename: H W
authors.initials: HW
authors.lastname: Reesink
authors.forename: U E
authors.initials: UE
authors.lastname: Nydegger
authors.forename: G E
authors.initials: GE
authors.lastname: Tegtmeier
authors.forename: J
authors.initials: J
authors.lastname: Barbara
authors.forename: S
authors.initials: S
authors.lastname: Seidl
authors.forename: D G
authors.initials: DG
authors.lastname: Woodfield
authors.forename: K
authors.initials: K
authors.lastname: Okochi
authors.forename: A M
authors.initials: AM
authors.lastname: Couroucé
authors.forename: C L
authors.initials: CL
authors.lastname: Van der Poel
mesh_terms: D001782:Blood Donors; D001803:Blood Transfusion; D006678:HIV; D016174:Hepacivirus; D006515:Hepatitis B virus; D015368:Human T-lymphotropic virus 1; D015367:Human T-lymphotropic virus 2; D006801:Humans; D011786:Quality Control; D013587:Syphilis